News › Clinical Practice, Industry News, Patient Care

New Study Uncovers Genetic Links to Rosacea

April 1, 2015

Researchers have identified gene variants that suggest a genetic component for rosacea, which could lead to new treatment targets and a better understanding of this incurable skin disease.
In a study published online in the Journal of Investigative Dermatology (March 12, 2015), researchers from Stanford University’s department of dermatology and 23andMe, a personal genetics company, studied data from nearly 23,000 of the genetics company’s clients, including 2,618 rosacea cases. They identified two rosacea-associated single nucleotide polymorphisms (SNPs), one which replicated in another group of 29,481 people, including 3,205 rosacea cases.
Read more at Dermatology Times.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
    • Galderma to Acquire ZO Skin Health for $1.5 Billion
    • AscendPoint Agency Acquires Medical Marketing Whiz
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association
Advertisement